Skip to main content
. 2023 Aug 22;14:5112. doi: 10.1038/s41467-023-40715-x

Fig. 2. Difference in distant metastasis–free survival (DMFS) between HER2-low and HER2-0 patients.

Fig. 2

ac Kaplan–Meier curves and risk tables showing DMFS of HER2-low and HER2-0 breast cancers compared by two-sided log-rank test in the entire cohort (a), HR-positive subgroup (b) and HR-negative subgroup (c). Source data are provided as a Source Data file.